Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Nearly 30% of Youth with ASD Not Getting Treatment

JAMA Pediatrics; ePub 2018 Dec 3; Xu, Strathearn, et al

The prevalence of autism spectrum disorder (ASD) in the US is relatively high, and it varies substantially across US states, according to a recent study. Furthermore, almost 30% of US children with ASD did not receive behavioral or medication treatment, which calls for a critical need to understand and address the barriers for those children to receive appropriate treatments. Using data from the 2016 National Survey of Children’s Health, a nationwide, population-based, cross-sectional survey, researchers included 43,032 children aged 3 to 17 years. They found:

  • Of total participants, 22,072 (51.3%) were male, and the mean (SD) age was 10.7 (4.4) years.
  • The weighted prevalence of ever-diagnosed ASD and current ASD were 2.79% and 2.50%, respectively.
  • The state-level prevalence of ever-diagnosed ASD varied from 1.54% in Texas to 4.88% in Florida.
  • Nationally, about 70% of children with current ASD (70.5%) were treated; 43.3% received behavioral treatment only, 6.9% received medication treatment only, and 20.3% received both behavioral and medication treatments.
  • The remaining 29.5% of children with current ASD did not receive either behavioral or medication treatment.

Citation:

Xu G, Strathearn L, Liu B, et al. Prevalence and treatment patterns of autism spectrum disorder in the United States, 2016. [Published online ahead of print December 3, 2018]. JAMA Pediatrics. doi:10.1001/jamapediatrics.2018.4208.